Key result
Permanent pacemaker implantation successfully treated a 60-year-old man with Guillain-Barré syndrome who developed symptomatic second to third degree sino-atrial block with 2.8-second pauses.
Why the study?
Guidelines and evidence regarding optimal treatment of transvenous device lead thrombosis are lacking, leaving management dependent on individual clinical choice.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Vitamin K antagonists may be a safe and effective treatment for pacemaker lead thrombosis complicated by pulmonary embolism in patients with high bleeding risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pelaggi et al. (2022) conducted a case report in Guillain-Barré syndrome with sino-atrial block (n=1). Pacemaker implantation was evaluated on Resolution of symptomatic bradycardia. Permanent pacemaker implantation successfully treated a 60-year-old man with Guillain-Barré syndrome who developed symptomatic second to third degree sino-atrial block with 2.8-second pauses.
Synapse has enriched 10 related papers. Consider them for comparative context: